MedTrace Logo

Telemonitoring of Geriatric Cancer Patients Using Handheld Devices

NCT03196050 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2019-01-23

No results posted yet for this study

Summary

Cancer is becoming a chronic disease, with the requirement of a lifelong intake of cancer-controlling drugs. While young(er) patients may cope with this, geriatric cancer patients may require a more customized and tailored follow up.

Most elderly patients have multiple other diseases ("comorbidities") and, due to many other factors, may per se not tolerate or simply not follow anticancer therapies. This may not only impair quality of life (QoL), but on the long rung also the therapeutic outcome (survival).

Handheld devices provide a new reporting/communication tool for patients and health care providers. TeleGraPH will assess if these devices are a suitable communication modality in a cohort of geriatric cancer patients.

Conditions

Interventions

DEVICE

Handheld Device (Smart Phone)

Handheld device will be used for 3 tasks: 1x per day: status update ("how are you today"?) 1x per week: 10 questions on general health status 1x per month: EORTC QLQ-C30 questionnaire

Sponsors & Collaborators

  • Hector-Stiftung

    collaborator OTHER

  • humediQ global GmbH, Grünwald

    collaborator UNKNOWN

  • Vitaphone GmbH, Mannheim

    collaborator UNKNOWN

  • Universitätsmedizin Mannheim

    lead OTHER

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03196050 on ClinicalTrials.gov